Eupraxia Pharmaceuticals, Inc. (EPRX)
8.50
+0.38
(+4.68%)
USD |
NASDAQ |
Feb 20, 16:00
8.50
0.00 (0.00%)
After-Hours: 20:00
Eupraxia Pharmaceuticals EPS Diluted (Quarterly) : -0.1898 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| enGene Holdings, Inc. | -0.7383 |
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Edesa Biotech, Inc. | -0.2819 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.369M |
| Total Expenses (Quarterly) | 6.361M |
| Enterprise Value | 371.84M |
| Earnings Yield | -10.22% |
| Normalized Earnings Yield | -10.22 |